InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by O'Connor Donal, Director. Officer active across 2 companies, notably PERRIGO Co plc. Aggregated, 6 filings have been published. The latest transaction was disclosed on 14 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€67,9017,305 shares@ €9.29510.0035% mcap24.7% of flow
Ordinary Shares
SEC:0001625377-26-000002·
€67,9017,305 shares@ €9.29510.0035% mcap8.6% of flow
Ordinary Shares
SEC:0001625377-26-000002:0·
€241,3036,599 shares@ €36.56670.013% mcap30.5% of flow
Ordinary Shares
SEC:0001585364-22-000057:0·
09,852 shares0
Ordinary Shares
SEC:0001415889-22-004334:0·
€206,6035,804 shares@ €35.59670.011% mcap75.3% of flow
Ordinary Shares
SEC:0001585364-21-000058·
€206,6035,804 shares@ €35.59670.011% mcap26.1% of flow
Ordinary Shares
SEC:0001585364-21-000058:0·
6 of 6 declarations
About O'Connor Donal
Donal O'Connor is a Board Member at Perrigo Co plc and Theravance Biopharma, Inc. In these roles, he participates in the governance and strategic decision-making of the companies. Donal contributes to policy development and strategic direction, ensuring that the companies meet their objectives while adhering to ethical and compliance standards. His experience is a valuable asset to the boards.
